mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.08 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.08 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.09 |